McWherter Charles
Insider CIK 1588862 · NONE Sr. Vice President · ETNB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 67,700 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 56,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | U Tender | 2025-10-30 | 2025-10-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 56,400 | — | $0 | 56,400 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2025-01-22 | 2025-01-23 | 10,000 | $6.71 | $67.1K | 25,000 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2025-01-21 | 2025-01-23 | 5,000 | $6.55 | $32.8K | 15,000 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2024-12-05 | 2024-12-09 | 10,000 | $8.00 | $80.0K | 10,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-08-05 | 2024-08-07 | 67,700 | — | $0 | 67,700 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 172,891 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 300,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 225,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 112,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 328,299 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 118,625 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 146,875 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 97,222 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 44,084 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 51,750 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 91,666 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 31,938 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 15,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 118,625 | — | $0 | 118,625 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award | 2024-01-24 | 2024-01-26 | 31,938 | — | $0 | 46,938 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-01-19 | 2024-01-22 | 8,334 | — | $0 | 91,666 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-01-19 | 2024-01-22 | 3,125 | — | $0 | 146,875 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-01-19 | 2024-01-22 | 2,250 | — | $0 | 51,750 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-01-19 | 2024-01-22 | 1,916 | — | $0 | 44,084 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-01-19 | 2024-01-22 | 2,778 | — | $0 | 97,222 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-01-19 | 2024-01-22 | 2,250 | $23.67 | $53.3K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-01-19 | 2024-01-22 | 2,778 | $1.72 | $4.8K | 17,778 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-01-19 | 2024-01-22 | 2,778 | $23.66 | $65.7K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-01-19 | 2024-01-22 | 1,916 | $1.82 | $3.5K | 16,916 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-01-19 | 2024-01-22 | 2,250 | $1.06 | $2.4K | 17,250 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-01-19 | 2024-01-22 | 8,334 | $10.00 | $83.3K | 23,334 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-01-19 | 2024-01-22 | 8,334 | $23.68 | $197.3K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-01-19 | 2024-01-22 | 3,125 | $11.69 | $36.5K | 18,125 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-01-19 | 2024-01-22 | 3,125 | $23.68 | $74.0K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-01-19 | 2024-01-22 | 1,916 | $23.66 | $45.3K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-18 | 6,504 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-18 | 704 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-18 | 3,890 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-18 | 234 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-12-18 | 2023-12-18 | 6,504 | $21.48 | $139.7K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-12-18 | 2023-12-18 | 6,504 | $5.00 | $32.5K | 21,504 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-12-18 | 2023-12-18 | 4,828 | $21.49 | $103.8K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-12-18 | 2023-12-18 | 4,828 | $5.00 | $24.1K | 19,828 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-17 | 2023-11-17 | 6,506 | — | $0 | 6,504 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-17 | 2023-11-17 | 708 | — | $0 | 704 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-17 | 2023-11-17 | 236 | — | $0 | 234 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-17 | 2023-11-17 | 3,892 | — | $0 | 3,890 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-11-17 | 2023-11-17 | 11,342 | $18.28 | $207.3K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-11-17 | 2023-11-17 | 11,342 | $5.00 | $56.7K | 26,342 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-18 | 2023-10-18 | 236 | — | $0 | 470 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-18 | 2023-10-18 | 3,892 | — | $0 | 7,782 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-18 | 2023-10-18 | 10,401 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-18 | 2023-10-18 | 708 | — | $0 | 1,412 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-18 | 2023-10-18 | 6,506 | — | $0 | 13,010 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-10-18 | 2023-10-18 | 21,743 | $14.07 | $305.9K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-10-18 | 2023-10-18 | 21,743 | $5.00 | $108.7K | 36,743 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-18 | 2023-09-19 | 3,892 | — | $0 | 11,674 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-18 | 2023-09-19 | 10,404 | — | $0 | 10,401 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-18 | 2023-09-19 | 708 | — | $0 | 2,120 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-18 | 2023-09-19 | 236 | — | $0 | 706 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-18 | 2023-09-19 | 6,506 | — | $0 | 19,516 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-09-18 | 2023-09-19 | 21,746 | $16.22 | $352.7K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-09-18 | 2023-09-19 | 21,746 | $5.00 | $108.7K | 36,746 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-18 | 2023-08-18 | 708 | — | $0 | 2,828 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-18 | 2023-08-18 | 6,506 | — | $0 | 26,022 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-18 | 2023-08-18 | 3,892 | — | $0 | 15,566 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-18 | 2023-08-18 | 236 | — | $0 | 942 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-18 | 2023-08-18 | 10,404 | — | $0 | 20,805 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-08-18 | 2023-08-18 | 21,746 | $5.00 | $108.7K | 36,746 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-08-18 | 2023-08-18 | 21,746 | $11.47 | $249.4K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-07-18 | 2023-07-19 | 6,506 | — | $0 | 32,528 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-07-18 | 2023-07-19 | 3,892 | — | $0 | 19,458 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-07-18 | 2023-07-19 | 708 | — | $0 | 3,536 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-07-18 | 2023-07-19 | 10,407 | — | $0 | 31,209 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-07-18 | 2023-07-19 | 236 | — | $0 | 1,178 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-07-18 | 2023-07-19 | 21,749 | $11.43 | $248.6K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-07-18 | 2023-07-19 | 21,749 | $5.00 | $108.7K | 36,749 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-06-20 | 2023-06-21 | 10,407 | — | $0 | 41,616 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-06-20 | 2023-06-21 | 3,892 | — | $0 | 23,350 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-06-20 | 2023-06-21 | 236 | — | $0 | 1,414 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-06-20 | 2023-06-21 | 708 | — | $0 | 4,244 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-06-20 | 2023-06-21 | 6,506 | — | $0 | 39,034 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-06-20 | 2023-06-21 | 21,749 | $5.00 | $108.7K | 36,749 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-06-20 | 2023-06-21 | 21,749 | $8.16 | $177.5K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-05-18 | 2023-05-19 | 10,407 | — | $0 | 52,023 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-05-18 | 2023-05-19 | 236 | — | $0 | 1,650 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-05-18 | 2023-05-19 | 3,892 | — | $0 | 27,242 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-05-18 | 2023-05-19 | 6,506 | — | $0 | 45,540 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-05-18 | 2023-05-19 | 708 | — | $0 | 4,952 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-05-18 | 2023-05-19 | 21,749 | $5.00 | $108.7K | 36,749 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-05-18 | 2023-05-19 | 21,749 | $9.08 | $197.5K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 112,000 | — | $0 | 112,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 328,299 | — | $0 | 328,299 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 172,891 | — | $0 | 172,891 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-11-02 | 2017-11-06 | 4,700 | $8.67 | $40.7K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-11-02 | 2017-11-06 | 300 | $8.67 | $2.6K | 10,300 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 200 | $7.43 | $1.5K | 8,300 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 1,700 | $7.43 | $12.6K | 10,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 3,000 | $7.43 | $22.3K | 8,100 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 100 | $7.42 | $742 | 5,100 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-01-19 | 2017-01-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-01-04 | 2017-01-06 | 23,000 | — | $0 | 46,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-12-30 | 2017-01-04 | 23,000 | — | $0 | 23,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2016-04-15 | 2016-04-19 | 3,000 | $1.68 | $5.0K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-01-26 | 2016-01-28 | 54,000 | — | $0 | 54,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2015-05-15 | 2015-05-19 | 600 | $3.17 | $1.9K | 1,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2015-05-15 | 2015-05-19 | 1,000 | $3.16 | $3.2K | 2,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2015-05-15 | 2015-05-19 | 400 | $3.14 | $1.3K | 400 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-01-07 | 2015-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2014-01-06 | 2014-01-08 | 52,046 | — | $0 | 52,046 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 5,660 | — | $0 | 5,660 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 31,134 | — | $0 | 31,134 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 1,886 | — | $0 | 1,886 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 1,886 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | D To issuer deriv | 2013-12-23 | 2013-12-27 | 5,660 | — | $0 | 0 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-10-31 | 2013-11-01 | 62,430 | — | $0 | 62,430 | SEC↗ |